OSR Holdings, Inc. - Common Stock (OSRH)
0.9303
-0.0497 (-5.07%)
NASDAQ · Last Trade: Jul 28th, 12:32 PM EDT
Detailed Quote
Previous Close | 0.9800 |
---|---|
Open | 1.000 |
Bid | 0.9251 |
Ask | 0.9439 |
Day's Range | 0.9061 - 1.000 |
52 Week Range | 0.9001 - 10.00 |
Volume | 175,716 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 922,043 |
Chart
News & Press Releases
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · July 25, 2025
Via Benzinga · July 25, 2025
Via Benzinga · July 18, 2025
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · July 18, 2025
Via Benzinga · July 3, 2025
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · May 22, 2025
In a market increasingly driven by breakthrough science and resource scarcity, a handful of sub-$2 stocks are making headlines with bold strategies, compelling partnerships, and game-changing data. From immunotherapy innovations to neuromodulation tech, metallic-rich exploration zones and wireless signal innovation, these companies are pushing the envelope—and attracting serious investor attention in the process.
Via AB Newswire · April 3, 2025
Via Benzinga · April 3, 2025
Via Benzinga · April 3, 2025
Via Benzinga · March 27, 2025
Via Benzinga · March 27, 2025
Via Benzinga · March 27, 2025
Health In Tech Inc. (NASDAQ: HIT), OSR Holdings Inc. (NASDAQ: OSRH), Theratechnologies Inc. (NASDAQ: THTX), and Leap Therapeutics Inc. (NASDAQ: LPTX) continue to push boundaries in healthcare through breakthroughs in insurtech, virtual access, immunotherapy, biologics, and precision oncology.
Via AB Newswire · March 26, 2025
Via Benzinga · March 26, 2025
Via Benzinga · March 26, 2025
Via Benzinga · March 26, 2025
Via Benzinga · March 26, 2025
Via Benzinga · March 26, 2025
Via Benzinga · March 19, 2025
Via Benzinga · March 19, 2025
Via Benzinga · March 18, 2025
Via Benzinga · March 13, 2025